Clinical trial with a new anti-Trichuris drug, trans-1,4,5,6 tetrahydro-2-(3-hydroxystyryl)-1-methyl pyrimidine (CP-14,445).
D000293:Adolescent; D000871:Anthelmintics / Q000009:adverse effects / Q000627:therapeutic use*; D002648:Child; D004304:Dosage Forms; D004305:Dose-Response Relationship, Drug; D004341:Drug Evaluation; D005243:Feces / Q000469:parasitology; D005260:Female; D006801:Humans; D007411:Intestinal Diseases, Parasitic / Q000188:drug therapy; D008297:Male; D010270:Parasite Egg Count; D011715:Pyrantel / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D012075:Remission, Spontaneous; D014257:Trichuriasis / Q000188:drug therapy* / Q000469:parasitology; D014258:Trichuris / Q000187:drug effects* / Q000469:parasitology
D000871:Anthelmintics; D004304:Dosage Forms; D011715:Pyrantel